PLCE1 and esophageal cancer: This study has also strongly suggested that the co-expression of PLCE1 and PRKCA could be an indicator for predicting of esophageal cancer patient outcomes, and the partnership of PLCE1 and PRKCA could be a therapeutic target instead of a single target for personalized therapy or prevention.